← Back to Partner Search

MYELOMA PATIENTS EUROPE AISBL

Organisation Other Belgium

BRUXELLES , Belgium

View EC Europa Profile

Projects

Interests Submitted

935347818

PIC

935347818

Reference

Projects

CERTAINTY

A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT

HORIZON Signed HORIZON-HLTH-2023-TOOL-05

ASCERTAIN

Affordability and Sustainability improvements by using new pricing, Cost-Effectiveness and ReimbursemenT models to Appraise iNnovative health technologies

HORIZON Signed HORIZON-HLTH-2022-IND-13

CARAMBA

SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease

H2020 Signed H2020-SC1-2017-Two-Stage-RTD

SISAQOL-IMI

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

H2020 Signed H2020-JTI-IMI2-2019-18-two-stage

MMpredict

Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients

H2020 Signed H2020-FTIPilot-2015-1

Main Collaborations

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (WURZBURG, DE)

ERASMUS UNIVERSITEIT ROTTERDAM (ROTTERDAM, NL)

UNIVERSITETET I OSLO (OSLO, NO)

OPTIMEDIS AG (HAMBURG, DE)

INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (ESCH SUR ALZETTE, LU)

HELMHOLTZ-ZENTRUM DRESDEN-ROSSENDORF EV (DRESDEN, DE)

CRITICAL PATH INSTITUTE STICHTING (AMSTERDAM, NL)

EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (Brussels, BE)

KATHOLIEKE UNIVERSITEIT LEUVEN (LEUVEN, BE)

UNIVERSITY OF LEEDS (LEEDS, UK)

Work Programmes

H2020 HORIZON

Additional Information

VAT: BE0842182407

Validation Status: 31042522